JOSEPH WHITFIELD: Open Payments
NPI 1265495683 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,493 in 227 payments from 18 companies in 2025. Trend: 2023 $3,729 · 2024 $4,380 · 2025 $4,493
Food & beverage: $4,381Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $645 |
| Supernus Pharmaceuticals, Inc. | 42 | $539 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $487 |
| Alkermes, Inc. | 32 | $484 |
| Corium, LLC | 26 | $456 |
| Collegium Pharmaceutical, Inc. | 12 | $312 |
| Neurocrine BioSciences, Inc. | 12 | $276 |
| ABBVIE INC. | 8 | $218 |
| Vanda Pharmaceuticals Inc. | 14 | $210 |
| Otsuka America Pharmaceutical, Inc. | 5 | $197 |
Products named: CAPLYTA, ARISTADA, Qelbree, Azstarys, Jornay PM, AUSTEDO XR, UZEDY, INGREZZA.
Industry payments across TX — which companies pay providers there.
